Skip to main content
Premium Trial:

Request an Annual Quote

Fluxion Bio Lands NIH Grant for Antimicrobial Microfluidic Systems

NEW YORK (GenomeWeb News) – Microfluidic systems developer Fluxion Biosciences has received a Phase I grant from the National Institutes of Health to develop a platform for use in antimicrobial drug discovery and development programs, the company said today.
 
The San Francisco-based company did not disclose the amount of the grant and was not immediately available for comment.
 
The goal of the company’s research under the grant is to develop a higher throughput microfluidic system that will enable detection methods to enhance antimicrobial effectiveness and systems for conducting multi-point dose response curves, Fluxion said.
 
"The ability to rapidly screen and characterize antimicrobial compounds will be a powerful tool for developing the next generation of drug therapies," Carolyn Conant, grant project leader, said in a statement.

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.